T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Kaiser Aluminum
KALU
$2.99B
| $402K | ﹤0.01% |
5,079
-754
| -13% | -$70.5K |
|
2302
OraSure Technologies
OSUR
$277M
| $400K | ﹤0.01% |
147,538
+47,500
| +47% | +$236K |
|
|
ALX
2303
Alexander's
ALX
$1.4B
| $397K | ﹤0.01% |
1,785
+116
| +7% | +$28K |
|
2304
Arlo Technologies
ARLO
$1.54B
| $397K | ﹤0.01% |
63,240
+11,659
| +23% | +$85.3K |
|
2305
Brookfield Infrastructure
BIPC
$5.01B
| $397K | ﹤0.01% |
9,344
+773
| +9% | +$36.5K |
|
2306
Zeta Global
ZETA
$7.44B
| $397K | ﹤0.01% |
+87,747
| New | +$770K |
|
2307
Acushnet Holdings
GOLF
$5.25B
| $396K | ﹤0.01% |
9,512
+172
| +2% | +$7.09K |
|
2308
AMC Global Media
AMCX
$496M
| $395K | ﹤0.01% |
13,580
+301
| +2% | +$10.6K |
|
2309
GrafTech
EAF
$203M
| $395K | ﹤0.01% |
5,585
+79
| +1% | +$6.88K |
|
|
GPMT
2310
Granite Point Mortgage Trust
GPMT
$58.8M
| $395K | ﹤0.01% |
41,271
+289
| +0.7% | +$2.95K |
|
2311
Community Trust Bancorp
CTBI
$1.44B
| $393K | ﹤0.01% |
9,708
+147
| +2% | +$5.98K |
|
2312
Cardlytics
CDLX
$25.1M
| $392K | ﹤0.01% |
1,758
+118
| +7% | +$39.5K |
|
2313
Futu Holdings
FUTU
$14.7B
| $392K | ﹤0.01% |
7,500
-42,717
| -85% | -$1.61M |
|
|
DHC
2314
Diversified Healthcare Trust
DHC
$2.03B
| $391K | ﹤0.01% |
214,579
+51,844
| +32% | +$118K |
|
2315
NETGEAR
NTGR
$647M
| $391K | ﹤0.01% |
21,125
+1,525
| +8% | +$31.1K |
|
2316
Camden National
CAC
$996M
| $389K | ﹤0.01% |
8,841
+86
| +1% | +$3.86K |
|
2317
Central Pacific Financial
CPF
$1B
| $388K | ﹤0.01% |
18,103
+139
| +0.8% | +$3.37K |
|
|
GOOD
2318
Gladstone Commercial Corp
GOOD
$641M
| $388K | ﹤0.01% |
20,598
+186
| +0.9% | +$3.78K |
|
2319
Copa Holdings
CPA
$6.17B
| $387K | ﹤0.01% |
6,114
+104
| +2% | +$7.33K |
|
|
ZEUS
2320
DELISTED
Olympic Steel
ZEUS
| $386K | ﹤0.01% |
14,997
-3,126
| -17% | -$105K |
|
|
PTRA
2321
DELISTED
Proterra Inc. Common Stock
PTRA
| $386K | ﹤0.01% |
83,295
+25,595
| +44% | +$157K |
|
2322
Banner Corp
BANR
$2.5B
| $385K | ﹤0.01% |
6,847
-5,137
| -43% | -$287K |
|
|
NVTA
2323
DELISTED
Invitae Corporation
NVTA
| $385K | ﹤0.01% |
157,966
-62,190
| -28% | -$275K |
|
2324
Health Catalyst
HCAT
$132M
| $381K | ﹤0.01% |
26,287
+5,804
| +28% | +$99K |
|
|
MGI
2325
DELISTED
MoneyGram International, Inc. New
MGI
| $381K | ﹤0.01% |
38,124
+2,872
| +8% | +$28.9K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.